XML 20 R6.htm IDEA: XBRL DOCUMENT v3.20.2
INTERIM CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
QualityTech, LP
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
QualityTech, LP
Series A Preferred Stock
Series A Preferred Stock
QualityTech, LP
Series B Preferred Stock
Series B Preferred Stock
QualityTech, LP
Total stockholders' equity
Total stockholders' equity
Cumulative Effect, Period of Adoption, Adjustment
Total stockholders' equity
Series A Preferred Stock
Total stockholders' equity
Series B Preferred Stock
Preferred Stock
Preferred Stock
QualityTech, LP
Limited Partner
Common stock
Common stock
QualityTech, LP
Limited Partner
Common stock
QualityTech, LP
General Partner
Common stock
Cumulative Effect, Period of Adoption, Adjustment
QualityTech, LP
Limited Partner
Common stock
Series A Preferred Stock
QualityTech, LP
Limited Partner
Common stock
Series B Preferred Stock
QualityTech, LP
Limited Partner
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated other comprehensive income (loss)
QualityTech, LP
Accumulated dividends in excess of earnings
Accumulated dividends in excess of earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated dividends in excess of earnings
Series A Preferred Stock
Accumulated dividends in excess of earnings
Series B Preferred Stock
Noncontrolling interests
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201602Member us-gaap:AccountingStandardsUpdate201602Member                                                    
Beginning balance, shares at Dec. 31, 2018                         7,443 7,443 51,123 57,799 1                      
Beginning balance at Dec. 31, 2018 $ 1,296,687 $ 1,296,687 $ (1,813) $ (1,813)         $ 1,193,986 $ (1,813)     $ 407,477 $ 407,477 $ 511 $ 886,866 $ 0 $ (1,813)     $ 1,062,473 $ 2,073 $ 2,344 $ (278,548) $ (1,813)     $ 102,701
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Net share activity through equity award plan (in shares)                             231 229                        
Net share activity through equity award plan 741 741             663           $ 3 $ 741         660             78
Increase (decrease) in fair value of derivative contracts (9,853) (9,853)             (8,775)                         (8,775) (9,853)         (1,078)
Equity-based compensation expense 3,300 3,300             2,928             $ 3,300         2,928             372
Adjustment to expenses net from Series B Convertible Preferred stock offering (42) (42)             (42)       (42) (42)                            
Proceeds net of fees from common equity offering (in shares)                             4,000 4,000                        
Proceeds net of fees from common equity offering 158,663 158,663             148,690           $ 40 $ 158,663         148,650             9,973
Dividends declared on Preferred Stock         $ (1,906) $ (1,906) $ (5,139) $ (5,139)     $ (1,906) $ (5,139)             $ (1,906) $ (5,139)           $ (1,906) $ (5,139)  
Dividends declared to common stockholders (24,371) (24,371)             (24,371)             (24,371)               (24,371)        
Dividends declared to noncontrolling interests (2,935)               0                                     (2,935)
Partnership distributions   (2,935)                           (2,935)                        
Net income 21,148 21,148             19,558             21,148               19,558       1,590
Ending balance at Mar. 31, 2019 1,434,480 1,434,480             1,323,779       $ 407,435 $ 407,435 $ 554 $ 1,034,554 $ 0       1,214,711 (6,702) (7,509) (292,219)       110,701
Ending balance, shares at Mar. 31, 2019                         7,443 7,443 55,354 62,028 1                      
Beginning balance, shares at Dec. 31, 2018                         7,443 7,443 51,123 57,799 1                      
Beginning balance at Dec. 31, 2018 1,296,687 1,296,687 $ (1,813) $ (1,813)         1,193,986 $ (1,813)     $ 407,477 $ 407,477 $ 511 $ 886,866 $ 0 $ (1,813)     1,062,473 2,073 2,344 (278,548) $ (1,813)     102,701
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Increase (decrease) in fair value of derivative contracts (34,192) (34,192)                                                    
Dividends declared on Preferred Stock (21,135) (21,135)                                                    
Net income 35,271 35,271                                                    
Ending balance at Sep. 30, 2019 1,473,812 1,473,812             1,364,261       $ 407,435 $ 407,435 $ 582 $ 1,098,651 $ 0       1,326,087 (28,900) (32,274) (340,943)       109,551
Ending balance, shares at Sep. 30, 2019                         7,443 7,443 58,238 64,906 1                      
Beginning balance, shares at Mar. 31, 2019                         7,443 7,443 55,354 62,028 1                      
Beginning balance at Mar. 31, 2019 1,434,480 1,434,480             1,323,779       $ 407,435 $ 407,435 $ 554 $ 1,034,554 $ 0       1,214,711 (6,702) (7,509) (292,219)       110,701
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Net share activity through equity award plan (in shares)                             37 31                        
Net share activity through equity award plan 179 179             505             $ 179         505             (326)
Increase (decrease) in fair value of derivative contracts (18,606) (18,606)             (16,608)                         (16,608) (18,606)         (1,998)
Equity-based compensation expense 4,296 4,296             3,832             4,296         3,832             464
Dividends declared on Preferred Stock         (1,906) (1,906) (5,139) (5,139)     (1,906) (5,139)             (1,906) (5,139)           (1,906) (5,139)  
Dividends declared to common stockholders (24,377) (24,377)             (24,377)             (24,377)               (24,377)        
Dividends declared to noncontrolling interests (2,932)               0                                     (2,932)
Partnership distributions   (2,932)                           (2,932)                        
Net income 7,535 7,535             7,483             7,535               7,483       52
Ending balance at Jun. 30, 2019 1,393,530 1,393,530             1,287,569       $ 407,435 $ 407,435 $ 554 $ 1,012,210 $ 0       1,219,048 (23,310) (26,115) (316,158)       105,961
Ending balance, shares at Jun. 30, 2019                         7,443 7,443 55,391 62,059 1                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Net share activity through equity award plan (in shares)                             15 15                        
Net share activity through equity award plan 260 260             239             $ 260         239             21
Increase (decrease) in fair value of derivative contracts (5,733) (5,733)             (5,207)                         (5,207) (5,733)         (526)
Foreign currency translation adjustments (426) (426)             (383)                         (383) (426)         (43)
Equity-based compensation expense 4,457 4,457             3,979             $ 4,457         3,979             478
Proceeds net of fees from settlement of forward shares (in shares)                             2,832 2,832                        
Proceeds net of fees from settlement of forward shares 109,490 109,490             102,849           $ 28 $ 109,490         102,821             6,641
Dividends declared on Preferred Stock (7,045) (7,045)     (1,906) (1,906) (5,139) (5,139)     (1,906) (5,139)             (1,906) (5,139)           (1,906) (5,139)  
Dividends declared to common stockholders (24,377) (24,377)             (24,377)             (24,377)               (24,377)        
Dividends declared to noncontrolling interests (2,932)               0                                     (2,932)
Partnership distributions   (2,932)                           (2,932)                        
Net income 6,588 6,588             6,637             6,588               6,637       (49)
Ending balance at Sep. 30, 2019 1,473,812 1,473,812             1,364,261       $ 407,435 $ 407,435 $ 582 $ 1,098,651 $ 0       1,326,087 (28,900) (32,274) (340,943)       109,551
Ending balance, shares at Sep. 30, 2019                         7,443 7,443 58,238 64,906 1                      
Beginning balance, shares at Dec. 31, 2019                         7,443 7,443 58,228 64,901 1                      
Beginning balance at Dec. 31, 2019 1,444,451 1,444,451             1,337,817       $ 407,435 $ 407,435 $ 582 $ 1,064,481 $ 0       1,330,444 (24,642) (27,465) (376,002)       106,634
Partners' Capital, Beginning Balance at Dec. 31, 2019   1,444,451                                                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Net share activity through equity award plan (in shares)                             240 238                        
Net share activity through equity award plan (1,458) (1,458)             (1,309)           $ 3 $ (1,458)         (1,312)             (149)
Increase (decrease) in fair value of derivative contracts (36,715) (36,715)             (33,155)                         (33,155) (36,715)         (3,560)
Foreign currency translation adjustments (223) (223)             (201)                         (201) (223)         (22)
Equity-based compensation expense 4,875 4,875             4,377             $ 4,875         4,377             498
Proceeds net of fees from settlement of forward shares (in shares)                             1,930 1,930                        
Proceeds net of fees from settlement of forward shares 83,217 83,217             78,535           $ 19 $ 83,217         78,516             4,682
Dividends declared on Preferred Stock         (1,906) (1,906) (5,139) (5,139)     (1,906) (5,139)             (1,906) (5,139)           (1,906) (5,139)  
Dividends declared to common stockholders (28,393) (28,393)             (28,393)             (28,393)               (28,393)        
Dividends declared to noncontrolling interests (3,133)               0                                     (3,133)
Partnership distributions   (3,133)                           (3,133)                        
Net income 8,120 8,120             8,010             8,120               8,010       110
Ending balance at Mar. 31, 2020 $ 1,463,696 1,463,696             1,358,636       $ 407,435 $ 407,435 $ 604 $ 1,120,664 $ 0       1,412,025 (57,998) (64,403) (403,430)       105,060
Ending balance, shares at Mar. 31, 2020                         7,443 7,443 60,398 67,069 1                      
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201815Member                                                      
Beginning balance, shares at Dec. 31, 2019                         7,443 7,443 58,228 64,901 1                      
Beginning balance at Dec. 31, 2019 $ 1,444,451 1,444,451             1,337,817       $ 407,435 $ 407,435 $ 582 $ 1,064,481 $ 0       1,330,444 (24,642) (27,465) (376,002)       106,634
Partners' Capital, Beginning Balance at Dec. 31, 2019   1,444,451                                                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Increase (decrease) in fair value of derivative contracts (34,856) (34,856)                                                    
Dividends declared on Preferred Stock (21,135) (21,135)                                                    
Net income 25,236 25,236                                                    
Ending balance at Sep. 30, 2020 1,621,836 1,621,836             1,508,114       $ 407,435 $ 407,435 $ 644 $ 1,276,715 $ 0       1,614,508 (56,480) (62,314) (457,993)       113,722
Ending balance, shares at Sep. 30, 2020                         7,443 7,443 64,442 71,101 1                      
Partners' Capital, Ending Balance at Sep. 30, 2020   1,621,836                                                    
Beginning balance, shares at Mar. 31, 2020                         7,443 7,443 60,398 67,069 1                      
Beginning balance at Mar. 31, 2020 1,463,696 1,463,696             1,358,636       $ 407,435 $ 407,435 $ 604 $ 1,120,664 $ 0       1,412,025 (57,998) (64,403) (403,430)       105,060
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Net share activity through equity award plan (in shares)                             1 1                        
Net share activity through equity award plan (1,360) (1,360)             (1,225)             $ (1,360)         (1,225)             (135)
Increase (decrease) in fair value of derivative contracts (3,641) (3,641)             (3,382)                         (3,382) (3,641)         (259)
Foreign currency translation adjustments 64 64             58                         58 64         6
Equity-based compensation expense 6,081 6,081             5,477             $ 6,081         5,477             604
Proceeds net of fees from settlement of forward shares (in shares)                             1,033 1,032                        
Proceeds net of fees from settlement of forward shares 50,455 50,455             47,178           $ 10 $ 50,455         47,168             3,277
Dividends declared on Preferred Stock         (1,906) (1,906) (5,139) (5,139)     (1,906) (5,139)             (1,906) (5,139)           (1,906) (5,139)  
Dividends declared to common stockholders (28,389) (28,389)             (28,389)             (28,389)               (28,389)        
Dividends declared to noncontrolling interests (3,134)               0                                     (3,134)
Partnership distributions   (3,134)                           (3,134)                        
Net income 10,209 10,209             9,892             10,209               9,892       317
Ending balance at Jun. 30, 2020 1,486,936 1,486,936             1,381,200       $ 407,435 $ 407,435 $ 614 $ 1,147,481 $ 0       1,463,445 (61,322) (67,980) (428,972)       105,736
Ending balance, shares at Jun. 30, 2020                         7,443 7,443 61,432 68,102 1                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Net share activity through equity award plan (in shares)                             62 51                        
Net share activity through equity award plan 1,397 1,397             1,261           $ 1 $ 1,397         1,260             136
Increase (decrease) in fair value of derivative contracts 5,500 5,500             4,692                         4,692 5,500         808
Foreign currency translation adjustments 166 166             150                         150 166         16
Equity-based compensation expense 8,247 8,247             7,443             $ 8,247         7,443             804
Proceeds net of fees from settlement of forward shares (in shares)                             2,948 2,948                        
Proceeds net of fees from settlement of forward shares 151,758 151,758             142,389           $ 29 $ 151,758         142,360             9,369
Dividends declared on Preferred Stock (7,045) (7,045)     $ (1,906) $ (1,906) $ (5,139) $ (5,139)     $ (1,906) $ (5,139)             $ (1,906) $ (5,139)           $ (1,906) $ (5,139)  
Dividends declared to common stockholders (28,901) (28,901)             (28,901)             (28,901)               (28,901)        
Dividends declared to noncontrolling interests (3,129)               0                                     (3,129)
Partnership distributions   (3,129)                           (3,129)                        
Net income 6,907 6,907             6,925             6,907               6,925       (18)
Ending balance at Sep. 30, 2020 $ 1,621,836 1,621,836             $ 1,508,114       $ 407,435 $ 407,435 $ 644 $ 1,276,715 $ 0       $ 1,614,508 $ (56,480) $ (62,314) $ (457,993)       $ 113,722
Ending balance, shares at Sep. 30, 2020                         7,443 7,443 64,442 71,101 1                      
Partners' Capital, Ending Balance at Sep. 30, 2020   $ 1,621,836